Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers
View ORCID ProfileEtienne Brochot, Baptiste Demey, View ORCID ProfileAntoine Touzé, View ORCID ProfileSandrine Belouzard, View ORCID ProfileJean Dubuisson, Jean-Luc Schmit, Gilles Duverlie, View ORCID ProfileCatherine Francois, View ORCID ProfileSandrine Castelain, View ORCID ProfileFrancois Helle
doi: https://doi.org/10.1101/2020.05.12.20098236
Etienne Brochot
1Department of Virology, Amiens University Medical Center, Amiens, France
2AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France
Baptiste Demey
1Department of Virology, Amiens University Medical Center, Amiens, France
2AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France
Antoine Touzé
3ISP1282 INRA University of Tours, Tours, France
Sandrine Belouzard
4Université Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France
Jean Dubuisson
4Université Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France
Jean-Luc Schmit
1Department of Virology, Amiens University Medical Center, Amiens, France
2AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France
Gilles Duverlie
1Department of Virology, Amiens University Medical Center, Amiens, France
2AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France
Catherine Francois
1Department of Virology, Amiens University Medical Center, Amiens, France
2AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France
Sandrine Castelain
1Department of Virology, Amiens University Medical Center, Amiens, France
2AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France
Francois Helle
2AGIR Research Unit, UR UPJV 4294, Jules Verne University of Picardie, Amiens, France
Data Availability
Most of the data generated or analysed during this study are included in this published article (and its supplementary information files). Additional supporting data are available from the corresponding authors on request.
Posted May 18, 2020.
Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers
Etienne Brochot, Baptiste Demey, Antoine Touzé, Sandrine Belouzard, Jean Dubuisson, Jean-Luc Schmit, Gilles Duverlie, Catherine Francois, Sandrine Castelain, Francois Helle
medRxiv 2020.05.12.20098236; doi: https://doi.org/10.1101/2020.05.12.20098236
Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers
Etienne Brochot, Baptiste Demey, Antoine Touzé, Sandrine Belouzard, Jean Dubuisson, Jean-Luc Schmit, Gilles Duverlie, Catherine Francois, Sandrine Castelain, Francois Helle
medRxiv 2020.05.12.20098236; doi: https://doi.org/10.1101/2020.05.12.20098236
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12843)
- Forensic Medicine (12)
- Gastroenterology (838)
- Genetic and Genomic Medicine (4650)
- Geriatric Medicine (427)
- Health Economics (735)
- Health Informatics (2957)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (937)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4437)
- Nursing (239)
- Nutrition (653)
- Oncology (2308)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1204)
- Primary Care Research (506)
- Public and Global Health (7036)
- Radiology and Imaging (1557)
- Respiratory Medicine (926)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)